This four-page brochure tells the story of the Uniject device--how it grew from a concept to an easy-to-use, all-in-one injection device that will be used to vaccinate every newborn in Indonesia against hepatitis B and to help eliminate maternal and neonatal tetanus globally. The publication covers the development, evaluation, licensing, production, and design and function of Uniject. Photographs and a timeline of Uniject's history included.
Corporate author(s): PATH
Publication date: 2003
190 KB PDF
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA